← All companiesVVERTEX PHARMACEUTICALS INC / MA
VRTX - CIK 0000875320
VERTEX PHARMACEUTICALS INC / MA net income by year
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported net income of $3.95B for fiscal year 2025, as filed in its audited annual report with the SEC.
VRTX annual net income
VRTX net income 2011-2025
| Fiscal year | Net Income | Change |
|---|
| FY 2025 | $3.95B | +838.1% |
| FY 2024 | -$535.60M | -114.8% |
| FY 2023 | $3.62B | +9.0% |
| FY 2022 | $3.32B | +41.8% |
| FY 2021 | $2.34B | -13.6% |
| FY 2020 | $2.71B | +130.4% |
| FY 2019 | $1.18B | -43.9% |
| FY 2018 | $2.10B | +695.8% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does VERTEX PHARMACEUTICALS INC / MA make?
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported net income of $3.95B for fiscal year 2025, as filed in its audited annual report with the SEC.
How has VERTEX PHARMACEUTICALS INC / MA's net income changed over time?
Between fiscal 2011 and fiscal 2025, VERTEX PHARMACEUTICALS INC / MA's net income grew from $29.57M to $3.95B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.